What is the difference between Ozempic and Mounjaro maintenance dosing
The session used the earliest available published data for CT-388 (24-week interim from ADA/ENDO 2024) and projected a 48-week plateau of 24 to 26% based on trajectory extrapolation from tirzepatide's weight-loss kinetics
The real success is being able to treat obesity, and thats what we should stick to
Salminen A, Hyttinen JM, Kaarniranta K
The peptide stack calculator helps plan multi-compound protocols, and the dosage calculation guide ensures accuracy across multiple compounds
Monitoring your health while using a GLP-1 receptor agonist is important, and certain symptoms or situations, such as the ones below, should prompt a consultation with a doctor: New or worsening gastrointestinal symptoms, such as persistent nausea, vomiting, diarrhoea, or signs of dehydration 7 , 27